Trump policies, China's biotech boom are ending Europe's pharma powerhouse era
Cercetare și inovare
Once the go-to location for global drugmakers, Europe is now being squeezed by President Donald Trump's aggressive trade and drug-pricing policies on one side, and China's explosive biotech boom on the other. The pharma industry is a cornerstone of Europe's economy, but the continent's declining competitiveness has companies looking elsewhere to place investments. And the issue isn't just economic. New launches of critical medicines are at stake, as prices and regulations discourage companies
astăzi